Kedrion Biopharma supports the 2020 Primary Immunodeficiency Week
The company stands alongside the global PI community
World Hemophilia Day: socially distant but still united with patients
Now more than ever, Kedrion is renewing its commitment to those who live with this rare disorder
Kedrion supports live streaming of medical debate on the use of convalescent plasma to treat Covid-19
Online roundtable “The Gift of the Cured versus the Pandemic” on air at DonatoriH24 on April 16
Kedrion alongside IPOPI at the IPIC Congress in Madrid
The importance of early diagnosis and the most recent innovations in the treatment of PID patients were the focus
Kedrion keeps Hemophilia therapy debate flowing in Latin America
A recent CLAHT Congress symposium restates current and future role of replacement therapy
Kedrion reaffirms its commitment for the global eradication of Rh disease
A worldwide initiative for maternal and fetal health launches in Florence, Italy
Leading medical-scientific event on Hemophilia held in Trieste, Italy
Kedrion-organized congress put replacement therapy, personalization and access to care in the spotlight
Kedrion scientific symposium at the 2019 PNS Conference in Genoa, Italy
A chance for world Key Opinion Leaders to debate possible new therapies for the treatment of CIPN
June 27 and 28 in Trieste (Italy), a two-day event dedicated to hemophilia
Replacement therapy, personalization and access to treatment are the main themes of the congress organized by Kedrion
16th International Hemophilia Congress in Turkey
A scientific symposium on the prevention and eradication of inhibitors in patients affected by Hemophilia A